Key result
TNF-alpha activates eNOS via sphingolipid signaling, inhibiting E-selectin expression and dendritic cell adhesion.
Answers are grounded in this paper and cite their sources.
Demonstrates that TNF-alpha activates eNOS via sphingolipid signaling in human endothelial cells, indicating an anti-inflammatory pathway regulating immune cell adhesion.
OBJECTIVE: Tumor necrosis factor alpha (TNF-alpha), a key proinflammatory cytokine acting on the endothelium, activates endothelial nitric oxide synthase (eNOS). We have examined the signaling pathway leading to this activation and its biological role in endothelium, which are still unknown. METHODS AND RESULTS: In human endothelial cells, we found that eNOS activation by TNF-alpha is time dependent and requires activation of Akt, a known eNOS activator. eNOS activation was preceded by sequential activation of neutral-sphingomyelinase-2 (N-SMase2) and sphingosine-kinase-1 (SK1) and generation of sphingosine-1-phosphate (Sph1P). Inhibition of N-SMase2 inhibited Sph1P formation, whereas inhibition of SK1 did not affect N-SMase2 activation by TNF-alpha. Blockade of N-SMase2, SK1, or the Sph1P receptors S1P1 and S1P3, either by silencing or pharmacological inhibitors, prevented eNOS activation. Thus, eNOS is activated by TNF-alpha via S1P receptors, activated by Sph1P generated through N-SMase2 and SK1 activation. We found that nitric oxide generated through this pathway has a biological role, because it inhibits the expression of E-selectin and the adhesion of dendritic cells to the endothelium stimulated by TNF-alpha. CONCLUSIONS: This study establishes a previously undescribed link among TNF-alpha, Sph1P, and eNOS in a same signaling pathway of biological relevance in the process of endothelial cell activation by TNF-alpha.
No takes yet. Share an insight, caveat, or question.
Palma et al. (2005) studied Endothelial cell activation. Tumor necrosis factor alpha (TNF-alpha) with or without blockade of N-SMase2, SK1, S1P1, or S1P3 vs. Gene silencing or pharmacological inhibitors of N-SMase2, SK1, S1P1, and S1P3 was evaluated on Endothelial nitric oxide synthase (eNOS) activation, E-selectin expression, and dendritic cell adhesion. TNF-alpha activates eNOS in human endothelial cells via N-SMase2, SK1, and S1P1/S1P3 receptors, inhibiting E-selectin expression and dendritic cell adhesion.
Synapse has enriched 10 related papers. Consider them for comparative context: